Glenmark Pharma launches anti-diabetes drug Remogliflozin in India - Business News: Latest Share Market , Economy & Finance News | Trendmergers

Home Stocks Glenmark Pharma launches anti-diabetes drug Remogliflozin in India

Glenmark Pharma launches anti-diabetes drug Remogliflozin in India

Stocks,

Glenmark said it will commercialise Remogliflozin in India under the brand names 'Remo' and 'Remozen'.

from Stocks-Markets-Economic Times
Read The Rest:economictimes...

All Copyright @ Trendmergers Team

Crafted With By Templatesyard | Distributed By Gooyaabi Templates

Breaking

Post Top Ad

Post Top Ad

Glenmark Pharma launches anti-diabetes drug Remogliflozin in India

Post Top Ad

Recent

Contact

Footer menu

Post Of the day

Popular Posts

Contact Form